VKTX
Viking Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
VKTX fundamentals
Viking Therapeutics (VKTX) released its earnings on Oct 22, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.81 (YoY -268.18%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.81
-268.18%
Report date
Oct 22, 2025
Earnings Call
4:30 PM on Oct 22, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
Key Indicators
Viking Therapeutics (VKTX) key financial stats and ratios, covering profitability, financial health, and leverage.
Viking Therapeutics (VKTX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Viking Therapeutics (VKTX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Viking Therapeutics (VKTX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Viking Therapeutics (VKTX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Viking Therapeutics (VKTX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Viking Therapeutics's earnings call?What does Viking Therapeutics do and what are its main business segments?What were the key takeaways from Viking Therapeutics’s earnings call?What factors drove the changes in Viking Therapeutics's revenue and profit?What is the market's earnings forecast for Viking Therapeutics next quarter?Did Viking Therapeutics beat or miss consensus estimates last quarter?What guidance did Viking Therapeutics's management provide for the next earnings period?What is the revenue and EPS growth rate for Viking Therapeutics year over year?
